Patients’ Right to Know Their Medication Act of 2023
- Last Action
- 3/3/2023
Actions
- 2023-03-03Referred to the Subcommittee on Health.
- 2023-02-24Referred to the House Committee on Energy and Commerce.
- 2023-02-24Introduced in House
- 2023-02-24Introduced in House
CRS Summary
As of 2023-02-24 (00)
Patients' Right to Know Their Medication Act of 2023
This bill establishes requirements relating to the form, content, and distribution of patient safety labels for prescription drugs.
Specifically, the Food and Drug Administration must issue regulations with requirements relating to the authorship, content, format, color, printing, and dissemination of such patient safety information. The regulations must require labels to include the drug's approved uses, known interactions with other drugs or substances, contact information for the drug's manufacturer, and other specified information relating to patient safety. The information must be in plain, neutral language and must be given in printed form with each prescription.
Cosponsors (15)
- Jared Golden (D-ME)
- Bruce Westerman (R-AR)
- C. A. Ruppersberger (D-MD)
- ZOE LOFGREN (D-CA)
- Chellie Pingree (D-ME)
- Yvette Clarke (D-NY)
- David Trone (D-MD)
- Terri Sewell (D-AL)
- Jefferson Van Drew (R-NJ)
- Chris Pappas (D-NH)
- Jill Tokuda (D-HI)
- Bradley Schneider (D-IL)
- Mary Peltola (D-AK)
- Marie Perez (D-WA)
- Salud Carbajal (D-CA)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.